with Virginia Commonwealth University (VCU) to investigate Aramchol's potential in overcoming drug resistance in gastrointestinal (GI) cancers. Under the Sponsored Project Agreement, VCU scientists will study Aramchol in preclinical models of...
can significantly enhance patient safety and efficacy." About Gene by Gene: Gene by Gene is a world leader in genetic testing services with over 20 years of experience. Our laboratory holds accreditation from multiple agencies, including CAP, CLIA,...
Food and Drug Administration (FDA)'s groundbreaking step announced last week to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drug candidates with more effective, human-relevant...
despite treatment with standard-of-care blood thinners like heparin and aspirin. These patients have the greatest need for better treatments. Dr. Salmon’s preclinical research in experimental models showed that inflammation in the developing...
has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in Muenster, Germany. Ridom´s NGS bioinformatics software SeqSphere+™ is designed for genomic...
may enable more targeted therapies. Additionally, MSK-ACCESS® powered with SOPHiA DDMTM, an innovative liquid biopsy test being deployed globally with the support of AstraZeneca, will be made available as a Precision for Medicine service for...
2D ion chromatography with mass spectrometry, and with high selectivity and sensitivity, every batch receives a nitrite test result on the certificate of analysis. Each batch of Low Nitrite METHOCEL™ is tested to ensure nitrite levels are...
1 mg (volume per vial) *This product can be provided with an Animal Component Free (ACF) certificate. *This product is for testing and research use only (RUO). *There is a possibility that the specifications can change.
quality." Ko-Chung Lin, Ph.D., Founder and CEO of PharmaEssentia, added, "The approval of BESREMi® by ANVISA is a testament to the power of strong cross-border partnerships in advancing healthcare and reinforces our mission to transform care for PV...
Medit a global leader in digital dentistry, has launched its latest All-on-X solution, Medit SmartX. This innovative solution empowers implant clinicians to fully leverage the potential of the digital ecosystem. Medit SmartX integrates with a wide...
Prize is an incredible honor, a milestone in my scientific and personal journey from a town in Poland to one of the greatest scientific centers in the United States," says Tomasz Nowakowski, winner of the 2024 Vilcek Prize for Creative Promise in...
authorities, and sharing of the preliminary data, this now opens the way for the Phase 2 portion of the Phase 1/2 trial to test innovative dosing regimens, with the goal of optimising outcomes for patients. This Phase 2 portion of the study will...
Oral FZ002 is a live yeast genetically modified to express a tetraspecific anti-toxin for C. difficile in the gastrointestinal (GI) tract. FZ002 is a first-in-class multi-benefit C. difficile treatment, offering potent and broad-spectrum...
in Europe as MYSIMBA, has been studied extensively in both randomized clinical trials and observational settings. The latest analysis builds upon prior research, including the LIGHT trial, and complements the ongoing INFORMUS trial, a large-scale...
a contract development organization, Kenox offers extensive expertise in formulation design, compounding, fill-finish, and testing in compliance with compendial monographs. About Lactiga US, Inc.: Lactiga is a biotechnology company developing novel...
(NGS) early on. They have a strong track record of successful commercialisation and bringing clinical diagnostics tests to the market. Pathnova specialises in the development and manufacturing of diagnostic products, including the creation of...
(CML) and acute lymphoblastic leukemia, myelodysplastic syndrome /myeloproliferative disease (MDS/MPD), and gastrointestinal tumors (GIST). “We’re proud to support Shorla’s next phase of growth,” said Jim Lang, CEO, EVERSANA. “Our collaboration...
with LabConnect." As the world's most agile central laboratory solutions partner, LabConnect will leverage ACL's extensive test menu with a comprehensive range of services to support the region including in-country lab kit building, biospecimen...
through the transdermal delivery route and that bypass the limitations of oral delivery including the well-known gastrointestinal adverse effects from extended use of high doses of oral curcumin. Dr. Joel Friedman, Professor, Department of...
insights. This integration allows for the seamless delivery of pharmacogenomic (PGx) risk assessments, advanced diagnostic test results, and ongoing PGx monitoring, empowering them to deliver better and more personalized resident care, allowing...
